| Brand Name | Tagrix |
| Packaging Type | Strip |
| Molecule | Osimertinib |
| Generic Name | Osimertinib |
| Manufactured By | Beacon Pharmaceuticals |
| Quantity | 30 Tablets |
| Form | Tablets |
| Country of Origin | India |
| Categories | Oncology |
Introduction to Tagrix 80mg
Tagrix 80mg Tablet is a targeted therapy used to treat non-small cell lung cancer (NSCLC) in patients with specific mutations in the epidermal growth factor receptor (EGFR). Tagrix 80mg is manufactured by Beacon Pharmaceuticals. The active ingredient, Osimertinib, is a third-generation tyrosine kinase inhibitor (TKI) that helps block the abnormal EGFR proteins responsible for uncontrolled cell growth and tumor formation. The FDA approves Osimertinib for locally advanced, unresectable (stage III) non-small cell lung cancer following chemoradiation therapy.
Tagrix 80 mg medication is especially effective in treating NSCLC patients with the T790M mutation, which makes tumors resistant to previous EGFR-TKI treatments. Tagrix 80mg is the first global generic version of Osimertinib and has been approved for use in many countries.
Uses of Tagrix 80mg Tablet
- First-line treatment for metastatic NSCLC with EGFR mutations.
- Adjuvant therapy for patients with NSCLC after complete surgical removal of tumors to prevent cancer recurrence.
- Treatment for patients whose NSCLC has progressed after other EGFR-targeting therapies.
How Tagrix 80mg Tablet Works
Tagrix 80mg works by inhibiting the activity of abnormal EGFR proteins in cancer cells. By blocking these proteins, Tagrix 80mg tablet slows or stops the growth and spread of cancer cells, particularly in lung cancer with specific EGFR mutations.
How to Consume Tagrix 80mg Tablet
- Take Tagrix 80mg exactly as prescribed by the patient’s doctor.
- Swallow the tablet whole with water. Do not chew, crush, or break it.
- You can take it with or without food but try to take it at the same time each day for consistent results.
Drug Interactions
Certain medications may affect how Tagrix works, or Tagrix may affect the effectiveness of other drugs like Antifungal medications, Anticonvulsants, Rifampin (an antibiotic), and Blood thinners (e.g., warfarin)
Please always inform the patient's healthcare provider about all medications and supplements you take to avoid interactions.
Side Effects of Tagrix 80mg Tablet
Precautions
Avoid using Tagrix 80mg medication if you are pregnant or planning to become pregnant. 
Consult a patient's doctor if you are breastfeeding.
Use with caution if you have liver or kidney issues. Dose adjustments may be needed.
Tagrix may cause heart rhythm changes. Inform a patient-doctor if you have any history of heart disease or irregular heartbeat.Tagrisso targets non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Follow your doctor’s instructions regarding any restrictions on food, beverages, or activities. In particular, avoid grapefruit and grapefruit juice, as they can interfere with how Osimertinib works.
No, Osimertinib is not a traditional chemotherapy drug. It is a targeted therapy that specifically inhibits EGFR mutations involved in the growth and spread of non-small cell lung cancer (NSCLC).
Tagrisso is available in 40 mg and 80 mg doses. The appropriate dose depends on the patient's condition and is determined by the healthcare provider.
Tagrisso has a half-life of approximately 48 hours, meaning it stays in the body for several days after the last dose.
Tagrisso is expensive due to the high cost of research, development, clinical trials, and the complex manufacturing processes involved in producing targeted therapies like Osimertinib.
Some side effects of Tagrisso may subside as your body adjusts to the medication, while others may persist. It's important to consult your healthcare provider for guidance on managing side effects.
The effectiveness of Tagrisso is monitored through regular scans, imaging tests, and assessments of cancer markers by your healthcare provider. Improvement in symptoms may also indicate that the medication is working.
The duration of Tagrisso treatment depends on how well the medication is working and how well it is tolerated. Some patients take it for several months or years as long as it remains effective.
No, Tagrisso is neither chemotherapy nor immunotherapy. It is a targeted therapy specifically designed to inhibit mutated EGFR in certain types of lung cancer.
Tagrisso can remain effective for several months or even years, depending on the patient’s response and the progression of their cancer.
Tagrisso is not a cure for lung cancer, but it can significantly extend survival and delay disease progression in patients with advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
You can order Osimertinib by logging into your account on our website, adding the tablet to your cart, and proceeding to checkout. After successful payment, your order will be confirmed, and you will receive a confirmation email. You can also contact us via WhatsApp to place your order directly.
Yes, Tagrisso can interact with several drugs, including antiarrhythmics, antipsychotics, antibiotics, and supplements like St. John’s wort. These interactions may increase the risk of side effects or make Tagrisso less effective.
Yes, Tagrisso may reduce fertility in both males and females. If you're concerned about future fertility, talk to your doctor about options like sperm or egg preservation.
No, Tagrisso is not safe during pregnancy or breastfeeding. Use birth control while taking Tagrisso and for several weeks after your last dose.
There are several alternatives to Tagrisso for treating non-small cell lung cancer, including other targeted therapies, immunotherapies, and traditional chemotherapy options. The best alternative depends on the specific characteristics of your cancer and should be discussed with your healthcare provider.
